UBS noted that Owens & Minor's weaker Q2 2025 results led to a price target reduction, while also discussing debt reduction plans.
1 report, 1 independent
Updated Aug 23
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
UBS noted that Owens & Minor's weaker Q2 2025 results led to a price target reduction, while also discussing debt reduction plans.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
UBS
Swiss multinational investment bank and financial services company
-
Owens & Minor
healthcare logistics company
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- Insider MonkeyUBS Reduces PT on Owens & Minor, Inc. (OMI) from $13 to $7 Following Weaker Q2 2025 Results With a price-to-earnings multiple under 15x and its relative strength index below 40, Owens & Minor, Inc. (